Supplementary downloadable tables

• Table INF-4. HIV infections newly diagnosed in injecting drug users, by year of report from 1992 to 2004, (a) cases per million population and (b) number of cases

• Table INF-5. Notified cases of hepatitis C infection among injecting drug users in the EU: number of IDU cases and percentage of IDUs among all cases with known risk factor

  • Table INF-5 part (i). Notifications of hepatitis C related to IDU, 1992 to 2004

  • Table INF-5 part (ii). Notes and comments, 1992 to 2004

• Table INF-6. Notified cases of hepatitis B infection among injecting drug users in the EU: number of IDU cases and percentage of IDUs among all notified cases with known risk factor

  • Table INF-6 part (i). Notifications hepatitis B related to IDU, 1992 to 2004

  • Table INF-6 part (ii). Notes and comments, 1992 to 2004

• Table INF-7. Incidence studies of hepatitis C virus infection among injecting drug users in the EU

• Table INF-8. Prevalence of HIV infection (percentage) among injecting drug users

  • Table INF-8 part (i). HIV prevalence in IDUs - Data, 1991 to 2004

  • Table INF-8 part (ii). HIV prevalence in IDUs - Notes, 1991 to 2004

• Table INF-9. Prevalence of HIV infection (percentage) among injecting drug users under age 25

  • Table INF-9 part (i). HIV prevalence young IDUs - Data, 1991 to 2004

  • Table INF-9 part (ii). HIV prevalence young IDUs - Notes, 1991 to 2004

• Table INF-10. Prevalence of HIV infection (percentage) among new injecting drug users (injecting less than 2 years)

  • Table INF-10 part (i). HIV prevalence new IDUs - Data, 1991 to 2004

  • Table INF-10 part (ii). HIV prevalence new IDUs - Notes, 1991 to 2004

• Table INF-11. Prevalence of hepatitis C infection (percentage) among injecting drug users

  • Table INF-11 part (i). HCV prevalence in IDUs - Data, 1991 to 2004

  • Table INF-11 part (ii). HCV prevalence in IDUs - Notes, 1991 to 2004

• Table INF-12. Prevalence of hepatitis C infection (percentage) among injecting drug users under age 25

  • Table INF-12 part (i). HCV prevalence young IDUs - Data, 1991 to 2004

  • Table INF-12 part (ii). HCV prevalence young IDUs - Notes, 1991 to 2004

• Table INF-13. Prevalence of hepatitis C infection (percentage) among new injecting drug users (injecting less than 2 years)

  • Table INF-13 part (i). HCV prevalence new IDUs - Data, 1991 to 2004

  • Table INF-13 part (ii). HCV prevalence new IDUs - Notes, 1991 to 2004

• Table INF-14. Prevalence of current hepatitis B infection (percentage with HBsAg) among injecting drug users

  • Table INF-14 part (i). HBsAg prevalence in IDUs - Data, 1991 to 2004

  • Table INF-14 part (ii). HBsAg prevalence in IDUs - Notes, 1991 to 2004

• Table INF-15. Prevalence of antibodies against hepatitis B virus (percentage) among injecting drug users

  • Table INF-15 part (i). HBV antibody prevalence in IDUs - Data, 1991 to 2004

  • Table INF-15 part (ii). HBV antibody prevalence in IDUs - Notes, 1991 to 2004